Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-13

Clinical Trial Update: STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection [NA]

View source ↗

Summary

Clinical trial STOP-CDI compares fecal microbiota transplantation with fidaxomicin and vancomycin for treatment and prevention of relapse in Clostridioides diff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)
  • Fidaxomicin (fidaxomicin)
  • Vancomycin (vancomycin)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence | NA | Status: NOT_YET_RECRUITING